Exploratory identification of candidate biomarkers and molecular contributors to paclitaxel-induced peripheral neuropathy in patients with breast cancer through proteomic analysis - Quiz - MDSpire

Exploratory identification of candidate biomarkers and molecular contributors to paclitaxel-induced peripheral neuropathy in patients with breast cancer through proteomic analysis

  • By

  • Nobuyoshi Kittaka

  • Hideaki Tahara

  • Takashi Akazawa

  • Yu Mizote

  • Takashi Kitajima

  • Keiichi Minami

  • Yurika Sugano

  • Takahiro Nakayama

  • June 16, 2026

  • 0 min

Share

Original Source(s)

Exploratory identification of candidate biomarkers and molecular contributors to paclitaxel-induced peripheral neuropathy in patients with breast cancer through proteomic analysis

  • by Nobuyoshi Kittaka, Hideaki Tahara, Takashi Akazawa, Yu Mizote, Takashi Kitajima, Keiichi Minami, Yurika Sugano, Takahiro Nakayama

  • June 16, 2026

Related Content

Global research trends of TCM-based nonpharmacologic interventions in breast cancer supportive care: a bibliometric analysis (2000–2025)

Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis

Barriers, Facilitators, and Intention to Use AI for Breast Cancer Diagnosis: Mixed Methods Study Among Austrian Physicians With and Without AI Experience